person

Ulrike S.

Country
France
Department
Radiotherapy

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
124
Sites with multiple studies

Has run more than one trial at 124 of 326 partner sites.

Specializations

Prostate Cancer Research

Primary focus on investigating therapeutic approaches for high-risk prostate cancer and biochemically recurrent disease. The investigator studies innovative treatment combinations involving targeted therapies and radiation.

  • Hormone-Sensitive Disease Management
  • Advanced Therapeutic Combinations
  • Oligometastatic Disease Treatment

Particular interest in evaluating novel antiandrogen treatments including darolutamide and apalutamide in combination with radiotherapy.

Head and Neck Cancer Studies

Specializes in developing treatment strategies for squamous cell carcinoma of the head and neck, with emphasis on combining immunotherapy with conventional treatments.

  • Immunotherapy Integration
  • Radiation Therapy Optimization
  • Novel Drug Combinations

Expert in evaluating immune checkpoint inhibitors such as durvalumab and nivolumab in combination with radiotherapy.

Advanced Therapeutic Approaches

Investigates innovative treatment modalities including stereotactic body radiotherapy and combination approaches for various cancer types.

  • Precision Radiation Techniques
  • Multi-Modal Treatment Strategies
  • Novel Drug Development

Specializes in developing personalized therapeutic approaches for locally advanced cancers and metastatic disease.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.